Inovio Pharmaceuticals (GBM.F) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.75
-0.58
-0.41
-0.24

Details

Expected EPS
-0.29869
Actual EPS
-0.23895200000000003
Surprise EPS
0.06
Surprise Percent
+20%

Description

Inovio Pharmaceuticals (GBM.F) has reported earnings of -0.23895200000000003 per share for Q2 2026.

0 Comments

Share your thoughts